FORM 2 - Corporate Substantial Shareholder Notice
 
Form Serial Number: CS20230606E00205
(Superseded by CS20230721E00650) 
1. Date of relevant event: 01/06/2023
(dd/mm/yyyy)
2. Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): 05/06/2023
(dd/mm/yyyy)
3. Stock code: 09939
4. Name of listed corporation: Kintor Pharmaceutical Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 447,499,600
7. Name of substantial shareholder: Nomura Holdings, Inc. 
8. Registered office: 1-13-1 Nihonbashi, Chuo-ku, Tokyo 103-8645, Japan
9. Principal place of business in Hong Kong: N/A 
15. Exchange on which listed: Tokyo, Nagoya, Singapore and New York
16. Name of listed parent and exchange on which parent is listed: N/A 
17. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Nature of consideration
Long position
1104The percentage level of your interest in the shares has increased because:
you acquired a security interest in the shares
2201Interest of corporation controlled by you
 5,913,760
Short position 
 
 
 		            
18. Total shares immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position18,150,7854.06
Short position8720.00
19. Total shares immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position24,064,5455.38
Short position8720.00
20. Capacity in which interests disclosed in Box 19 are held:
Capacity codeNumber of shares
2201Interest of corporation controlled by you
Long position24,064,545
Short position872

21. Further information in respect of derivative interests:
Derivatives codeNumber of shares
4105Unlisted derivatives - Physically settled
Long position6,772,760
Short position0
22. Further information in relation to interests of corporations controlled by substantial shareholder:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Nomura International plc1 Angel Lane London EC4R 3AB, United KingdomNomura Europe Holdings plc100.00Y
Long position1,181,000
Short position872
Nomura Europe Holdings plc1 Angel Lane London EC4R 3AB, United KingdomNomura Holdings, Inc.100.00N
Long position1,181,000
Short position872
Nomura Singapore Limited10 Marina Boulevard #36-01 Marina Bay Financial Centre Tower 2 Singapore 018983Nomura Asia Pacific Holdings Co., Ltd100.00Y
Long position22,883,545
Short position0
Nomura Asia Pacific Holdings Co., Ltd1-13-1 Nihonbashi Chuo-ku Tokyo, JapanNomura Holdings, Inc.100.00N
Long position22,883,545
Short position0

23. Further information in relation to interests held by substantial shareholder jointly with another person:
Name of joint shareholderAddressNumber of shares
 
24. Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust:
Names of trustAddressStatus codeNumber of shares
  
25. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a substantial shareholder is interested under sections 317 and 318
26. Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act:
NamesAddressRelationship CodePercentage (%)
  
 
27. Supplementary information:
28. Log/Serial Number of the previous form:
29. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 2: 06/06/2023
(dd/mm/yyyy)